Microbot Medical Inc. (MBOT)

USD 0.97

(-3.69%)

Market Cap (In USD)

16.47 Million

Revenue (In USD)

-

Net Income (In USD)

-10.74 Million

Avg. Volume

156.87 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
0.82-2.35
PE
-
EPS
-
Beta Value
1.628
ISIN
US59503A2042
CUSIP
59503A204
CIK
883975
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Mr. Harel Gadot
Employee Count
-
Website
https://www.microbotmedical.com
Ipo Date
1992-03-25
Details
Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company, through its ViRob, TipCAT, CardioSert, and Liberty micro-robotic technologies, developing Self Cleaning Shunt for the treatment of hydrocephalus and normal pressure hydrocephalus; a disposable robot for various endovascular interventional procedures; and a multi generation pipeline portfolio. It has 42 issued/allowed patents and 23 patent applications pending worldwide. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts.